The effect of eucalyptus inhalation on pain and the quality of life in rheumatoid arthritis.

PROBLEM CONSIDERED

Pain is one of the most significant symptoms of rheumatoid arthritis that reduce the quality of life. The purpose of the study was to determine the effect of eucalyptus on pain and the quality of life in patients with rheumatoid arthritis.

METHODS

In this randomized clinical trial, 70 patients with rheumatoid arthritis were selected by random sampling. In the eucalyptus group, 1 mL of eucalyptus oil was inhaled for 5 min, 3 times a day, for one month. The control group received placebo inhalation. Both groups used routine treatments. Data were collected using a questionnaire of demographics, the numerical pain rating scale (NRS), and Quality of Life (SF-12). Statistical analysis was done using 19th edition SPSS software and applied on paired -test, chi-square, Fisher's exact test, and analysis of covariance.

RESULTS

The mean score of pain severity in the eucalyptus group significantly decreased in comparison with the control group (P < 0.001). The severity of pain there was no statistical difference in both groups before, the first, and the second weeks after the intervention, (p > 0.05); however, in the third and fourth weeks after the intervention, the mean severity of pain in the eucalyptus group was lower than in the control group, and these differences were statistically significant between the two groups (p < 0.05). Also, the patients' quality of life in the eucalyptus group was increased significantly (P < 0.001).

CONCLUSION

The eucalyptus leads to pain reduction, and consequently, improves the quality of life of patients with rheumatoid arthritis.

TRIAL REGISTRATION

IRCT20160110025929N15 Registration date: ; https://en.irct.ir/trial/33573.